• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

freseniuskabi

Fresenius Kabi has a Class I Ivenix infusion pump recall

January 12, 2024 By Sean Whooley

Fresenius Kabi Ivenix infusion system

The FDA determined that a recall of the Fresenius Kabi Ivenix large-volume infusion pump is Class I, the most serious kind. This recall affects the LVP-0004 model of the Ivenix large-volume pumps. Fresenius Kabi distributed these systems between Oct. 1, 2021, and July 31, 2023. In total, the company recalled 938 devices in the U.S. […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance Tagged With: FDA, Fresenius Kabi, freseniuskabi

Fresenius Kabi, Mayo Clinic ink deal on Ivenix infusion system

December 15, 2023 By Sean Whooley

Fresenius Kabi Ivenix infusion system

Fresenius Kabi announced that it signed a multi-year purchase agreement with Mayo Clinic centered around large-volume infusion pumps. The Lake Zurich, Illinois-based company expects Mayo Clinic to purchase 10,000 Ivenix pumps for hospitals and clinics in Minnesota, Arizona and Florida. It marks the largest contract for Ivenix pumps signed by the company to date. Ivenix, […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured, Hospital Care, Technology Tagged With: Fresenius Kabi, freseniuskabi, Ivenix

Fresenius Kabi launches single-needle option for extracorporeal photopheresis

April 24, 2023 By Sean Whooley

Fresenius Kabi logo updated

Fresenius Kabi announced the availability of a single-needle venous access option for its Amicus extracorporeal photopheresis (ECP) system. The company announced its availability at the 49th annual meeting of the European Society for Blood and Marrow Transplantation (EBMT). Fresenius Kabi first launched the Amicus Blue system with online ECP in Europe in 2019 with double-needle venous […]

Filed Under: Business/Financial News, Drug-Device Combinations, Vascular Tagged With: Fresenius Kabi, freseniuskabi

Fresenius Kabi launches Simplist Glycopyrrolate injection in U.S.

July 25, 2022 By Sean Whooley

Glycopyrrolate Simplist Fresenius Kabi

Fresenius Kabi announced today that its Glycopyrrolate injection in Simplist prefilled syringes has been made available in the U.S. The Fresenius Kabi Simplist Glycopyrrolate injection, USP, represents the most recent manufacturer-prepared product available in the company’s proprietary, ready-to-administer portfolio of Simplist prefilled syringes, which the company designed to reduce the amount of time nurses spend […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: freseniuskabi

Fresenius Kabi expands compatibility of radio frequency tagged medication

June 14, 2022 By Sean Whooley

Fresenius Kabi logo updated

Fresenius Kabi announced today that its portfolio of radio frequency tagged medications is now compatible with an AmerisourceBergen offering. Lake Zurich, Illinois-based Fresenius Kabi’s growing +RFID portfolio now has compatibility with AmerisourceBergen’s medication tray solution for helping hospitals improve medication inventory visibility and tracking using advanced radiofrequency identification (RFID) technology. Get the full story at […]

Filed Under: Auto-injectors, Business/Financial News, Hospital Care, Radiosurgery Tagged With: AmerisourceBergen, freseniuskabi

Fresenius Kabi to acquire Ivenix and its smart infusion system for $240M upfront

March 31, 2022 By Sean Whooley

Fresenius Kabi Ivenix

Fresenius Kabi announced today that it will acquire Ivenix with plans to bring a comprehensive infusion product portfolio to the U.S. The acquisition, which has a purchase price of $240 million upfront, also includes potential milestone payments linked to achievements of commercial and operating targets. According to a news release, the companies expect the acquisition […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceuticals Tagged With: Fresenius, freseniuskabi, Ivenix, mAbxience

FDA clears Fresenius Kabi wireless Agilia Connect infusion system

March 14, 2022 By Sean Whooley

Fresenius Kabi Agilia Connect Infusion System

Fresenius Kabi announced today that it received FDA 510(k) clearance for its wireless Agilia Connect infusion system. Lake Zurich, Illinois-based Fresenius Kabi’s Agilia Connect infusion system includes the Agilia volumetric pump and the Agilia syringe pump with Vigilant software suite-Vigilant Master Med technology. According to a news release, the two pumps are the first to […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA, freseniuskabi

Fresenius Kabi recalls sodium acetate injection due to presence of particulate matter

March 7, 2022 By Sean Whooley

Fresenius Kabi logo updated

Fresenius Kabi USA announced today that it initiated the voluntary recall of seven lots of its sodium acetate injection. Lake Zurich, Illinois-based Fresenius Kabi recalled the USP, 400 mEq/100 mL (4 mEq/mL), 100 mL fill in a 100 mL vial to the user level due to the presence of particulate matter found in reserve and/or […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance Tagged With: freseniuskabi

Government warns on cybersecurity issue with Fresenius Kabi’s Agilia Connect infusion system

December 21, 2021 By Sean Whooley

Fresenius Kabi logo updated

The U.S. Cyber Security & Infrastructure Security Agency today issued a medical advisory for the Fresenius Kabi Agilia Connect infusion system. Fresenius Kabi’s Agilia Connect infusion system has been deemed “exploitable remotely/low attack complexity” by the agency. Successful exploitation of vulnerabilities could allow an attacker to gain access to sensitive information, modify settings or parameters […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: freseniuskabi, infusion pump, infusion systems

Omnicell, Fresenius Kabi collaborate on controlled substance dispensers

November 10, 2021 By Sean Whooley

Omnicell Fresenius kabi

Omnicell (NSDQ:OMCL) and Fresenius Kabi announced today that they are collaborating on new technology for managing controlled substances. The collaboration aims to provide U.S. hospitals and health systems with innovative new pharmacy technology designed to support safety and efficiency in dispensing controlled substances in patient care areas. Omnicell designs a controlled substance dispenser (CSD) for […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: freseniuskabi, Omnicell

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS